Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study.
about
Moving away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE)--agents that concern prescribers and patients: a feasibility study and call for a trialSwitch to Ritonavir-Boosted versus Unboosted Atazanavir plus Raltegravir Dual-Drug Therapy Leads to Similar Efficacy and Safety Outcomes in Clinical PracticeAntiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort StudyModifying Antiretroviral Therapy in Virologically Suppressed HIV-1-Infected Patients.Brief Report: Switch to Ritonavir-Boosted Atazanavir Plus Raltegravir in Virologically Suppressed Patients With HIV-1 Infection: A Randomized Pilot Study.Dyslipidemia and cardiovascular risk in human immunodeficiency virus infection.Etravirine as a Switching Option for Patients with HIV RNA Suppression: A Review of Recent Trials.Etravirine combined with antiretrovirals other than darunavir/ritonavir for HIV-1-infected, treatment-experienced adults: Week 48 results of a phase IV trial.Antiretroviral regimens sparing agents from the nucleoside(tide) reverse transcriptase inhibitor class: a review of the recent literature.Switch strategies in antiretroviral therapy regimens.Pharmacokinetic and pharmacodynamic evaluation of raltegravir and experience from clinical trials in HIV-positive patients.Review of integrase strand transfer inhibitors for the treatment of human immunodeficiency virus infection.Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection.Clinical management of dyslipidaemia associated with combination antiretroviral therapy in HIV-infected patients.Two-Drug Treatment Approaches in HIV: Finally Getting Somewhere?Antiretroviral activity and safety of once-daily etravirine in treatment-naive HIV-infected adults: 48-week results.Aging in HIV-Infected Subjects: A New Scenario and a New View.
P2860
Q28540037-0899AE6D-27EF-4D08-ADCD-957EBFB44B41Q28553066-267D5B56-EB8C-4C25-A443-EA7D7625965CQ35814594-AA97E7AF-75CC-4539-9481-0339BBB0CA59Q36426953-A2029286-23AC-4B15-A275-8AC9634AF6D5Q36721002-E2B69638-295C-4B3E-BED9-299FBE12939FQ37319195-DA412F53-7686-476D-AB31-DABDED8EF997Q37639881-0E9B22D2-DE4D-415A-945F-05B5290AE5CDQ37722935-8EEB15A2-5E94-41DD-BE39-BD7C1FD42057Q38170576-89631167-B82A-4F47-B166-D09759506FA2Q38235295-590EE0DC-59B0-42D8-97EA-303036A30CAFQ38527537-A70DCFCA-2FFB-4452-9881-38C521D6CBBDQ38570500-E9BA1487-3035-4FCF-A778-FD961CB6CB87Q38620257-9FB3D0A4-FD6D-4892-B768-8FAD8C51F3C9Q38723259-433A1E73-80EA-4909-9E03-ACCE0FD202F2Q38737182-28B7CC22-FD79-42D0-AA57-147FA53EA165Q41059063-153D9853-1BB1-42C7-B975-EB0E6DAA7171Q50072732-61A97621-085B-48EF-8928-F5A5C6240131
P2860
Dual therapy with etravirine plus raltegravir for virologically suppressed HIV-infected patients: a pilot study.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Dual therapy with etravirine p ...... ected patients: a pilot study.
@en
Dual therapy with etravirine p ...... ected patients: a pilot study.
@nl
type
label
Dual therapy with etravirine p ...... ected patients: a pilot study.
@en
Dual therapy with etravirine p ...... ected patients: a pilot study.
@nl
prefLabel
Dual therapy with etravirine p ...... ected patients: a pilot study.
@en
Dual therapy with etravirine p ...... ected patients: a pilot study.
@nl
P2093
P2860
P356
P1476
Dual therapy with etravirine p ...... ected patients: a pilot study.
@en
P2093
Ana González-Cordon
Esteban Martínez
Iñaki Perez
Jose L Blanco
Jose M Gatell
Josep Mallolas
Maria Martínez-Rebollar
Montserrat Laguno
Montserrat Lonca
Polyana Monteiro
P2860
P304
P356
10.1093/JAC/DKT406
P407
P577
2013-10-14T00:00:00Z